Literature DB >> 31728905

Common tools for pituitary adenomas research: cell lines and primary cells.

Ziyan Zhu1, Weiwei Cui1, Dimin Zhu2, Nailin Gao2, Yonghong Zhu3.   

Abstract

PURPOSE: Pituitary tumor is the common primary brain tumor in humans. For further studying the pathogenesis and new therapeutic targets of pituitary adenoma, cell lines and primary cells are necessary tools. Different from primary cells that have short survival time and hormone secretion maintenance time, cell lines would be endowed with immortal characteristics under the help of gene modification. This review is to explore whether these cell lines still have similar pathophysiological changes in pituitary adenoma cells and methods to prolong the lifespan of pituitary adenoma primary cells.
RESULTS: In the cell lines summarized in the review, HP75, PDFS, HPA and GX were derived from human pituitary adenomas. It was found that the cell lines commonly used in articles published between January 2014 and July 2019 were GH3, AtT20, MMQ, GH4C1, HP75 and TtT/GF. Besides, it was glad that many methods had been used to prolong the lifespan and maintain characteristics of pituitary adenoma primary cells.
CONCLUSION: The paper reviews most of pituitary adenoma cell lines that have been successfully established since 1968 and the relevant situation of primary culture of pituitary adenoma cells. Obviously, it requires us to make more efforts to obtain human pituitary adenoma cell lines and prolong the lifespan of pituitary adenoma primary cells with maintaining their morphology and ability to secret hormones.

Entities:  

Keywords:  Cell lines; Pituitary adenomas; Primary cells; Review

Year:  2020        PMID: 31728905     DOI: 10.1007/s11102-019-01003-4

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  71 in total

Review 1.  Advances and controversies in the classification and grading of pituitary tumors.

Authors:  E R Laws; D L Penn; C S Repetti
Journal:  J Endocrinol Invest       Date:  2018-06-01       Impact factor: 4.256

2.  Glucocorticoid induction of growth hormone synthesis in a strain of rat pituitary cells.

Authors:  L Y Yu; R J Tushinski; F C Bancroft
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

3.  MicroRNAs and Target Genes in Pituitary Adenomas.

Authors:  Yajuan Feng; Zhi-Gang Mao; Xin Wang; Qiu Du; Mengyao Jian; Dimin Zhu; Zheng Xiao; Hai-Jun Wang; Yong-Hong Zhu
Journal:  Horm Metab Res       Date:  2018-03-09       Impact factor: 2.936

4.  Establishment in culture of a multihormone-secreting cell strain derived from the MtT/F4 rat pituitary tumor.

Authors:  U I Richardson
Journal:  J Cell Physiol       Date:  1976-07       Impact factor: 6.384

5.  A human pituitary tumor-derived folliculostellate cell line.

Authors:  D C Danila; X Zhang; Y Zhou; G R Dickersin; J A Fletcher; E T Hedley-Whyte; M K Selig; S R Johnson; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma.

Authors:  Y Kikuchi; K Seki; E Momose; I Kizawa; K Oomori; K Shima; K Mukai; K Kato
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

7.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.

Authors:  Ran Li; Zhuo Zhang; Junwen Wang; Yiming Huang; Wei Sun; Ruifan Xie; Feng Hu; Ting Lei
Journal:  Biomed Pharmacother       Date:  2017-09-08       Impact factor: 6.529

Review 9.  Diagnosis and Treatment of Pituitary Adenomas: A Review.

Authors:  Mark E Molitch
Journal:  JAMA       Date:  2017-02-07       Impact factor: 56.272

10.  Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.

Authors:  Fangfang Jian; Yufan Chen; Guang Ning; Wei Fu; Hao Tang; Xiao Chen; Yao Zhao; Lili Zheng; Sijian Pan; Weiqing Wang; Liuguan Bian; Qingfang Sun
Journal:  Oncotarget       Date:  2016-02-23
View more
  5 in total

1.  Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.

Authors:  Martin Franke; Adrian F Daly; Leonor Palmeira; Amit Tirosh; Antonio Stigliano; Eszter Trifan; Fabio R Faucz; Dayana Abboud; Patrick Petrossians; Juan J Tena; Eleonora Vitali; Andrea G Lania; José L Gómez-Skarmeta; Albert Beckers; Constantine A Stratakis; Giampaolo Trivellin
Journal:  Am J Hum Genet       Date:  2022-02-23       Impact factor: 11.043

2.  Pituitary Tumors and Immortalized Cell Lines Generated by Cre-Inducible Expression of SV40 T Antigen.

Authors:  Alexandre Z Daly; Amanda H Mortensen; Hironori Bando; Sally A Camper
Journal:  Endocrinology       Date:  2021-07-01       Impact factor: 4.736

Review 3.  Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches.

Authors:  Changxi Han; Shaojian Lin; Xingyu Lu; Li Xue; Zhe Bao Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-02       Impact factor: 5.555

4.  MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.

Authors:  Fan Yang; Zhanwen Sun; Dengyun Wang; Tian Du
Journal:  BMC Cancer       Date:  2022-03-22       Impact factor: 4.430

5.  PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.

Authors:  Kejing Zhu; Xueting Cheng; Shuman Wang; Hong Zhang; Yu Zhang; Xiong Wang; Yonggang Chen; Jinhu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-21       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.